StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a report released on Tuesday morning. The brokerage issued a sell rating on the stock. Ampio Pharmaceuticals Stock Up 3.7 % NYSE AMPE traded up $0.06 during trading hours on Tuesday, hitting $1.68. 42,078 shares of the company were exchanged, compared to […]

Related Keywords

Englewood ,Colorado ,United States , ,Vanguard Group Inc ,Pricet Rowe Associates Inc ,Ampio Pharmaceuticals Company Profile ,Ampio Pharmaceuticals Stock ,Ampio Pharmaceuticals ,Ampio Pharmaceuticals Inc ,Hedge Funds Weigh In On Ampio Pharmaceuticals ,News Ratings For Ampio Pharmaceuticals Daily ,Blackrock Inc ,Free Report ,Get Free Report ,Street Corp ,Ampio Pharmaceuticals Daily ,Nyse Ampe ,Ampe ,Medical ,Initiated Coverage ,Stocknews Com ,